"The U.S. Food and Drug Administration today approved Movantik (naloxegol), an oral treatment for opioid-induced constipation in adults with chronic non-cancer pain.
Opioids are a class of drugs that are used to treat and manage pain. A comm"...
Sucraid Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Sucraid (sacrosidase) Oral Solution is an enzyme replacement therapy used to treat sucrase deficiency that occurs in people with congenital sucrase-isomaltase deficiency (CSID). CSID is a genetic enzyme deficiency and this drug will not cure this condition. Common side effects include stomach pain, nausea, vomiting, diarrhea, constipation, insomnia, headache, nervous feeling, or increased thirst and dry, hot skin.
The recommended dosage of Sucraid is 1 or 2 mL (8,500 to 17,000 I.U.) or 1 or 2 full measuring scoops (each full measuring scoop equals 1mL; 28 drops from the Sucraid container tip equals 1mL) taken orally with each meal or snack diluted with 2 to 4 ounces of water, milk or infant formula. Sucraid may interact with other drugs. Tell your doctor all medications and supplements you use. Sucraid may be harmful to a fetus. Tell your doctor if you are pregnant or plan to become pregnant during treatment. Consult your doctor before breastfeeding.
Our Sucraid (sacrosidase) Oral Solution Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Patient Information in Detail?
Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.
Sucraid in Detail - Patient Information: Side Effects
Stop using this medication and get emergency medical help if you have any of these signs of an allergic reaction: hives; wheezing, difficulty breathing; swelling of your face, lips, tongue, or throat.
Less serious side effects may include:
- stomach pain;
- nausea, vomiting;
- diarrhea, constipation;
- sleep problems (insomnia);
- nervous feeling; or
- increased thirst and dry, hot skin.
Some of these may be symptoms of your condition and not actual side effects of sacrosidase.
Read the entire detailed patient monograph for Sucraid (Sacrosidase Oral Solution) »
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Sucraid FDA Prescribing Information: Side Effects
Adverse experiences with SUCRAID in clinical trials were generally minor and were frequently associated with the underlying disease.
In clinical studies of up to 54 months duration, physicians treated a total of 52 patients with SUCRAID. The adverse experiences and respective number of patients reporting each event (in parenthesis) were as follows: abdominal pain (4), vomiting (3), nausea (2), diarrhea (2), constipation (2), insomnia (1) headache (1) nervousness (1) and dehydration (1).
Note: diarrhea and abdominal pain can be a part of the clinical presentation of the genetically determined sucrase deficiency, which is part of congenital sucrase-isomaltase deficiency (CSID).
One asthmatic child experienced a serious hypersensitivity reaction (wheezing) probably related to sacrosidase (see WARNINGS). The event resulted in withdrawal of the patient from the trial but resolved with no sequelae.
Read the entire FDA prescribing information for Sucraid (Sacrosidase Oral Solution) »
Additional Sucraid Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.